Global Compounding Pharmacies Market Report 2020-2027

$3,000.00

Global Compounding Pharmacies Market Report 2020-2027

Description

Compounding Pharmacies Market is expected to reach USD 15.5 Billion till 2027growing at a CAGR of 6 % from 2021 to 2027. This is a global research study of 200 pages covering 29 countries. We have featured top 14 key players operating in Compounding Pharmacies all around the world in this report. Considering the base year of 2020, we providing historic data from 2014 to 2020 and forecasted data from 2021 to 2027.

The role of compounding Pharmacies is to customize the drug prescribed by health provider for particular patients with their specific needs.

Market Drivers  

Increasing adaptation of customized medicines in developed regions, increasing drug failure rate, Compounded Medicines are proving more beneficial; few are the reason due to which analyst predicts that the market is expected to reach USD 15.5 Billion till 2027.

Market Restraints

With Lack of skilled pharmacist in developed countries, Consumer behavior towards compounded drugs. Too high cost of equipment and maintenance of sterile environment are few of the market restraints for compound pharmacies market.

Market Segmentation

The compounding Pharmacies market report is segmented by Therapeutic Area, Product, Application, Compounding Type, Sterility, Distribution Channel and Region.

The Therapeutic area is further divided into Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements. The Product segment is further divided into Oral {Solid Preparations [Tablets, Capsules, Granules, Powder], Liquid Preparations [Solutions, Suspension, Emulsion, Syrup]}, Topical {Ointments, Creams, Gels, Pastes}, Rectal {Suppositories, Enema}, Parenteral {SVP, LVP}, Nasal, Ophthalmic, Otic. By Application the report is further segmented into (Pediatric, Adult, Geriatric, Veterinary. By Compounding type, the report is further segmented into Pharmaceutical Ingredient Alteration [PIA], Currently Unavailable Pharmaceutical Manufacturing [CUPM], Pharmaceutical Dosage Alteration [PDA]), By Sterility the report is further segmented into Sterile, Non-sterile. By distribution channel the report is further bifurcated into Hospital Pharmacy, Compounding Pharmacy.

 Geographical Analysis

Based on geography, the Compounded Pharmacies market is divided into North America, Europe, Asia-Pacific, South America and Middle East and Africa. North America is further divided into the US, Canada, Mexico whereas Europe consists of the UK, Germany, France, Italy and Rest of Europe. Asia-Pacific is segmented into Japan, South Korea, India, China and Rest of Asia-Pacific. The South America region includes Brazil, Argentina and the Rest of South America, while the Middle East and Africa is categorized into GCC Countries, Egypt, South Africa and Rest of Middle East and Africa.

Competitive Landscape

Key Player operating in Compounded Pharmacies Market are Strategy dashboard, 2020, Athenex Pharma Solutions (Athenex Inc.), B. Braun, Clinigen Group PLC, Dougherty’s Pharmacy, Inc., Fagron, Fresenius Kabi,   Institutional Pharmacy Solutions, Lorraine’s Pharmacy, McGuff Company Inc. (McGuff Compounding Pharmacy Services), Nephron Pharmaceuticals Corporation, Pencol Compounding Pharmacy, Rx3 Compounding Pharmacy, Triangle Compounding Pharmacies, Wedgewood Village Pharmacy, Inc..

Compounded Pharmacies Market Key Segments

By Therapeutic Area,

  • Hormone replacement
  • Pain management
  • Dermatology
  • Specialty drugs
  • Nutritional supplements
  • Others

By Product

  • Oral
    • Solid preparations
      • Tablets
      • Capsules
      • Granules
      • Powder
      • Others
    • Liquid preparations
      • Solutions
      • Suspension
      • Emulsion
      • Syrup
      • Others
  • Topical
    • Ointments
    • Creams
    • Gels
    • Pastes
    • Others
  • Rectal
    • Suppositories
    • Enema
    • Others
  • Parenteral
    • Small volume parenteral (SVP) solutions
    • Large volume parenteral (LVP) solutions
  • Nasal
  • Ophthalmic
  • Otic

By Application

  • Paediatric
  • Adult
  • Geriatric
  • Veterinary

By Compounding Type

  • Pharmaceutical Ingredient Alteration (PIA)
  • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • Pharmaceutical Dosage Alteration (PDA)
  • Others

By Sterility

  • Sterile
  • Non-sterile

By Distribution Channel

  • Hospital pharmacy
  • Compounding pharmacy
  • Others

By Region

  • North America (US, Canada, Mexico)
  • Europe (UK, Germany, France, Italy and Rest of Europe)
  • Asia-Pacific (Japan, South Korea, India, China and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and the Rest of South America)
  • Middle East and Africa (GCC Countries, Egypt, South Africa and Rest of Middle East and Africa)

By Key Players

  • Strategy dashboard, 2020,
  • Athenex Pharma Solutions (Athenex Inc.)
  • Braun
  • Clinigen Group PLC
  • Dougherty’s Pharmacy, Inc.
  • Fagron
  • Fresenius Kabi
  •  Institutional Pharmacy Solutions
  • Lorraine’s Pharmacy
  • McGuff Company Inc. (McGuff Compounding Pharmacy Services)
  • Nephron Pharmaceuticals Corporation
  • Pencol Compounding Pharmacy
  • Rx3 Compounding Pharmacy
  • Triangle Compounding Pharmacies
  • Wedgewood Village Pharmacy, Inc..

 

Reviews

There are no reviews yet.

Be the first to review “Global Compounding Pharmacies Market Report 2020-2027”

Your email address will not be published. Required fields are marked *

Name
Email
Phone
Enquiry